U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 97

Tests names and labsConditionsGenes, analytes, and microbesMethods

Multiple endocrine neoplasia IIA, 171400, Autosomal dominant; MEN2A (Multiple endocrine neoplasia type 2) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Multiple endocrine neoplasia IIA, 171400, Autosomal dominant; MEN2A (Multiple endocrine neoplasia type 2) (RET gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Multiple Endoctine Neoplasia Type 2 (RET)

Molecular Genetics Laboratory London Health Sciences Centre
Canada
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Plus Panel

BioReference Health
United States
9777
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Guideline Panel

BioReference Health
United States
7154
  • C Sequence analysis of the entire coding region

Hereditary Cancer Screening - Common Hereditary Cancer Panel (41 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
4741
  • X Mutation scanning of select exons

Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
5244
  • X Mutation scanning of select exons

Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
10999
  • X Mutation scanning of select exons

PREVENTEST

GeneID Lab - Advanced Molecular Diagnostics
United States
6034
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Thyroid Cancer - RET Gene Analysis

GeneKor MSA
Greece
41
  • E Sequence analysis of select exons

Invitae Expanded Renal Disease Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
693388
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Common Hereditary Cancer Screening Panel

PreventionGenetics, part of Exact Sciences
United States
9455
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoCancer

Centogene AG - the Rare Disease Company
Germany
11368
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene AG - the Rare Disease Company
Germany
155107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

RET - MLPA

Centogene AG - the Rare Disease Company
Germany
51
  • D Deletion/duplication analysis

RET - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Congenital Anomalies of Kidney and Urinary Tract (CAKUT) Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
6741
  • D Deletion/duplication analysis

Invitae Hypopigmentation Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
8346
  • D Deletion/duplication analysis

Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel

PreventionGenetics, part of Exact Sciences
United States
346160
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 97

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.